Zurich Cantonal Bank’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Hold
5,640
﹤0.01% 2044
2026
Q1
$361K Buy
+5,640
New +$391K ﹤0.01% 2004
2025
Q4
Sell
-2,988
Closed -$252K 3024
2025
Q3
$197K Sell
2,988
-59
-2% -$3.51K ﹤0.01% 2203
2025
Q2
$161K Sell
3,047
-29
-0.9% -$1.36K ﹤0.01% 2229
2025
Q1
$153K Buy
3,076
+209
+7% +$11.6K ﹤0.01% 2236
2024
Q4
$182K Hold
2,867
﹤0.01% 2193
2024
Q3
$141K Hold
2,867
﹤0.01% 2288
2024
Q2
$129K Buy
+2,867
New +$97.4K ﹤0.01% 2260

Other funds holding IRON

Zurich Cantonal Bank's IRON Position: Q2 2026 in Review

Zurich Cantonal Bank held its Disc Medicine (IRON) position steady in Q2 2026 at 5,640 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #2044.

Zurich Cantonal Bank first reported a position in IRON in Q2 2024 and has held it in 8 quarters since. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Zurich Cantonal Bank held 5,640 shares of Disc Medicine worth $413K as of Q2 2026.
  • Zurich Cantonal Bank left its Disc Medicine share count unchanged in Q2 2026.
  • Disc Medicine made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2044 holding.
  • Zurich Cantonal Bank first reported a position in Disc Medicine in Q2 2024 and has held it in 8 quarters since.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.